Business Development Bank of Canada

The Business Development Bank of Canada (BDC) is a government-owned financial institution established in 1944. Headquartered in Montreal, BDC specializes in providing financing, consulting services, and venture capital to small and medium-sized enterprises (SMEs) across Canada. Its services include business loans, corporate financing, and strategic planning, catering to a wide range of industries such as manufacturing, technology, and tourism. BDC operates through a network of over 100 offices, offering services in both official languages.

Trevor Allibon

Managing Director, Subordinate Financing

Timothy April

Managing Director

Kyle Feucht

Senior Director, Growth and Transition Capital

Jasmin Ganie-Hobbs

Director of Tech Financing

Lily Lam

Director, Funds

Patrick Latour

Senior Vice President

Sandy Li

Associate

Vern Malcolm

Managing Director, Growth and Transition Capital

Benoît Mignacco

Vice President, Digital Lending

Mona Minhas

Partner

Mike Notto

Partner

Jérôme Nycz

Executive Vice President

Matt Price

Managing Director, Growth and Transition Capital

Sal Rabbani

Managing Partner, Advisory Services

Andrianiaina Rajaobelina

Associate Principal

Chantal Remy

Senior Vice President, Quebec and Atlantic and Advisory Services

Victor Scutaru

Managing Director

Kunle Tauhid

Vice President, Financing and Consulting

Maxime Tourangeau

Partner

David Wan

Director, Growth and Transition Capital

Ronald Warburton

Managing Partner

Past deals in Vancouver

ZenHub

Seed Round in 2021
ZenHub is a project management software company founded in 2014 in Vancouver, British Columbia, by Matthew Butler. The software is designed to enhance the software development lifecycle for developers by enabling project planning directly within GitHub. It automates workflows to eliminate redundancies, extra steps, and hand-off delays, while utilizing live data to identify risks and bottlenecks. By creating real-time project roadmaps, ZenHub allows clients to focus more on coding and less on project management, ultimately streamlining the development process.

Intelligent City

Venture Round in 2019
Intelligent City Inc., founded in 2008 and based in Vancouver, Canada, specializes in the design and construction of urban housing. The company has developed a technology-enabled building platform aimed at addressing critical urban challenges such as affordability and sustainability. Its approach integrates various stages of construction—design, architecture, engineering, and fabrication—into a cohesive system. By leveraging principles of mass customization, Intelligent City combines the flexibility of personalized products with the cost-effectiveness of mass production. The company focuses on mass timber building services and employs advanced techniques, including passive house performance and automated manufacturing, to create housing solutions that are environmentally sustainable, socially responsible, and long-lasting.

Intelligent City

Debt Financing in 2019
Intelligent City Inc., founded in 2008 and based in Vancouver, Canada, specializes in the design and construction of urban housing. The company has developed a technology-enabled building platform aimed at addressing critical urban challenges such as affordability and sustainability. Its approach integrates various stages of construction—design, architecture, engineering, and fabrication—into a cohesive system. By leveraging principles of mass customization, Intelligent City combines the flexibility of personalized products with the cost-effectiveness of mass production. The company focuses on mass timber building services and employs advanced techniques, including passive house performance and automated manufacturing, to create housing solutions that are environmentally sustainable, socially responsible, and long-lasting.

Zymeworks

Post in 2019
Zymeworks Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada, focused on the discovery, development, and commercialization of innovative biotherapeutics for cancer treatment. The company's lead candidates include ZW25, a bispecific antibody undergoing Phase I and II clinical trials for various tumors, including biliary tract and gastroesophageal adenocarcinomas, and ZW49, a bispecific antibody-drug conjugate in Phase I trials for advanced HER2-expressing cancers. Zymeworks employs a computational biotechnology approach, utilizing proprietary molecular modeling and simulation technologies to optimize therapeutic antibodies and other protein-based therapeutics. The company has established strategic partnerships with notable organizations such as Merck, Eli Lilly, and Bristol-Myers Squibb, as well as collaborations aimed at advancing antibody discovery and development. Founded in 2003, Zymeworks is dedicated to addressing unmet medical needs through its advanced therapeutic platforms and integrated drug development capabilities.

LoginRadius

Angel Round in 2013
LoginRadius Inc. operates a cloud-based customer identity and access management platform aimed at mid-to-large sized businesses globally. Founded in 2011 and headquartered in Vancouver, Canada, with additional offices in India and the United States, the platform offers a range of services including customer registration, social login, profile management, and user management. Its developer-friendly solution features comprehensive APIs for authentication, identity verification, and multi-factor authentication, as well as customizable login interfaces and integrations with over 150 third-party applications. LoginRadius serves over 3,000 organizations and reaches approximately 1.17 billion consumers monthly. The company has been recognized as a significant player in the Consumer Identity and Access Management sector by industry analysts and maintains a partnership with Microsoft to enhance its offerings.

Axine Water Technologies

Seed Round in 2012
Axine Water Technologies Inc. is a Vancouver-based company specializing in innovative wastewater treatment solutions. Established in 2010, it focuses on developing chemical-free systems that effectively treat high concentrations of complex, toxic organics and ammonia found in industrial wastewater. Utilizing a proprietary electrolytic oxidation technology, Axine's systems can address a broad range of pollutants, including phenols, pharmaceuticals, dioxins, and various organic compounds, without generating sludge or requiring chemical additives. The company aims to provide cost-effective and energy-efficient alternatives to traditional wastewater treatment methods, catering to industries such as oil and gas, petrochemicals, pharmaceuticals, textiles, and waste management. Its solutions enable both industrial and municipal clients to enhance the performance and reduce the costs of their wastewater treatment processes.

Neuromed Pharmaceuticals

Series B in 2001
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.